For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the emergence of Tafamidis and Tafamidis meglumine represents a significant breakthrough . These novel therapies preserve the transthyretin protein, halting its harmful build-up and alleviating the impact of the disease . Patients are now seeing benefit… Read More